Zui Pan

Title: Zui Pan: Innovator in Calcium Modulation and Diabetes Risk Assessment

Introduction

Zui Pan is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the fields of cellular biology and medicine through his innovative patents. With a total of 2 patents, his work focuses on modulating calcium entry in cells and identifying risks associated with diabetes.

Latest Patents

Zui Pan's latest patents include "Compositions and methods for modulating store-operated calcium entry." This invention provides compositions that comprise the P311 protein, which is fused to a cell-penetrating peptide for effective delivery to tissues and cells. The P311 protein has been shown to enhance store-operated calcium entry (SOCE) in various cell types, including gingival cells, skeletal muscle cells, and prostate epithelial cells. Additionally, he has developed a "Method for identifying diabetic patients at increased risk for pathological complications." This method allows for the detection and measurement of plasma levels of endothelial cell antibodies, aiding in the diagnosis of increased risks of complications associated with diabetes.

Career Highlights

Throughout his career, Zui Pan has worked with esteemed organizations such as the University of Medicine and Dentistry of New Jersey and the United States Government, represented by the Department of Veterans Affairs. His work has had a profound impact on understanding cellular mechanisms and improving patient outcomes.

Collaborations

Zui Pan has collaborated with notable colleagues, including Jianjie Ma and Noah Weisleder. These partnerships have contributed to the advancement of research in his areas of expertise.

Conclusion

Zui Pan's innovative work in modulating calcium entry and assessing diabetes risk showcases his dedication to advancing medical science. His contributions continue to influence the fields of cellular biology and healthcare.